Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Di Carlo

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|June 5, 2003
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant micePatrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacyAntonio Rosato, Alessia Zoso, Gabriella Milan, et al.
Oncoimmunology|February 6, 2018
IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesisElisa Ferretti, Emma Di Carlo, Emanuela Ognio, et al.
The Journal of Clinical Investigation|June 3, 2004
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignanciesIrma Airoldi, Emma Di Carlo, Barbara Banelli, et al.
Cancer Research|May 17, 2003
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c micePaola Cappello, Frederic Triebel, Manuela Iezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2014
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymphPaolo Carrega, Irene Bonaccorsi, Emma Di Carlo, et al.
Cancer Research|November 19, 2004
Immunological prevention of a multigene cancer syndromeStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccineAlberto Comes, Ombretta Rosso, Anna Maria Orengo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-APatrizia Scapini, Monica Morini, Cristina Tecchio, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2019
Dendritic cell recognition by group 3 innate lymphoid cells through DNAX accessory molecule 1 triggers proinflammatory reciprocal cell activationStefania Campana, Emma Di Carlo, Claudia De Pasquale, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|June 5, 2003
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant micePatrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacyAntonio Rosato, Alessia Zoso, Gabriella Milan, et al.
Oncoimmunology|February 6, 2018
IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesisElisa Ferretti, Emma Di Carlo, Emanuela Ognio, et al.
The Journal of Clinical Investigation|June 3, 2004
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignanciesIrma Airoldi, Emma Di Carlo, Barbara Banelli, et al.
Cancer Research|May 17, 2003
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c micePaola Cappello, Frederic Triebel, Manuela Iezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2014
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymphPaolo Carrega, Irene Bonaccorsi, Emma Di Carlo, et al.
Cancer Research|November 19, 2004
Immunological prevention of a multigene cancer syndromeStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccineAlberto Comes, Ombretta Rosso, Anna Maria Orengo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-APatrizia Scapini, Monica Morini, Cristina Tecchio, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2019
Dendritic cell recognition by group 3 innate lymphoid cells through DNAX accessory molecule 1 triggers proinflammatory reciprocal cell activationStefania Campana, Emma Di Carlo, Claudia De Pasquale, et al.
Pageof 10